MARKET

GLMD

GLMD

Galmed Pharmaceu
NASDAQ
1.280
+0.040
+3.23%
After Hours: 1.221 -0.059 -4.63% 19:50 05/12 EDT
OPEN
1.200
PREV CLOSE
1.240
HIGH
1.290
LOW
1.160
VOLUME
506.53K
TURNOVER
--
52 WEEK HIGH
23.80
52 WEEK LOW
1.150
MARKET CAP
2.89M
P/E (TTM)
-0.1585
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLMD last week (0505-0509)?
Weekly Report · 17h ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 3d ago
Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)
TipRanks · 4d ago
Galmed announces results from Aramchol studies
TipRanks · 6d ago
Galmed Pharma: First Set Of Oncology Studies Show Aramchol Enhances Liver / Colorectal Cancer-approved Therapeutic Regorafenib Effects In Liver And Colon Cancers In-vitro And In-vivo Models
Benzinga · 6d ago
BRIEF-Galmed Announces First Time Results In Oncology Studies Aramchol Significantly Enhances Bayer's Regorafenib Effect In Gi Cancer Models
Reuters · 6d ago
GALMED PHARMACEUTICALS LTD - PHASE 1B STUDY OF ARAMCHOL AND REGORAFENIB TO START Q4 2025
Reuters · 6d ago
Weekly Report: what happened at GLMD last week (0428-0502)?
Weekly Report · 05/05 10:29
More
About GLMD
More
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.
Recently
Symbol
Price
%Change

Webull offers Galmed Pharmaceuticals Ltd stock information, including NASDAQ: GLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLMD stock methods without spending real money on the virtual paper trading platform.